Used in pharmaceutical research as a key intermediate in the synthesis of complex organic molecules targeting neurological disorders. Its unique bridged polycyclic structure makes it valuable for developing compounds with high selectivity toward central nervous system receptors. It is particularly explored in the context of novel antidepressant and neuroprotective agents due to its ability to cross the blood-brain barrier and modulate synaptic activity. Additionally, its structural rigidity supports use in structure-activity relationship (SAR) studies for optimizing drug candidates.